Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-018153
Filing Date
2020-07-01
Accepted
2020-07-01 17:34:22
Documents
2
Period of Report
2020-06-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1562
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4607
  Complete submission text file 0000899243-20-018153.txt   7539
Mailing Address 1000 WINTER ST. SUITE 2200 WALTHAM MA 02451
Business Address
Colangelo Dominick (Reporting) CIK: 0001313403 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38886 | Film No.: 201006216

Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Issuer) CIK: 0001563880 (see all company filings)

EIN.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations